Home » Newsletters » BioWorld Science

BioWorld Science

July 17, 2013

View Archived Issues

Characterization of a small-molecule dual receptor inhibitor that targets oncogenic pathways

Ipsen aims to expand neurology R&D capabilities with acquisition of Syntaxin

First-in-human results presented for LY-2951742

Pluristem's PLX cells tested for treatment of radiation poisoning

Novel tyrosine-protein kinase inhibitors disclosed by Allergan

A novel adeno-associated virus gene therapy for mucopolysaccharidosis IIIA

AbbVie presents new TRPV1 antagonists for pain and other disorders

Merck & Co. synthesizes novel Hdm2 inhibitors

Biosortia and AstraZeneca enter drug discovery research agreement

Oryzon obtains European orphan drug designation for ORY-1001 in AML

OncoGenex completes patient enrollment in Borealis-1 trial in metastatic bladder cancer

Life Technologies and Merck Serono enter collaboration

FDA accepts Iroko's NDA for low-dose submicron indomethacin

Chinese group divulges novel FLT3 inhibitors

Toyama Chemical presents phase II results for T-817MA

Advanomics receives research grant to advance lead anticancer candidate

New protein kinase and apoptosis inducers reported by Bayer

Updated xTAG CYP2D6 Kit receives FDA and European clearance

Medivir describes new agents for HCV infection

Sequella obtains exclusive worldwide license to TB treatment candidate from Pfizer

Abide Therapeutics and UC San Diego receive grant to validate MAGL target

New mouse model of CD30-positive T-cell lymphoma described

Qualigen obtains 510(k) clearance from FDA for FastPack Vitamin D Immunoassay

Paladin Labs becomes sole shareholder of Allon Therapeutics

Basilea provides update on phase III program for isavuconazole

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...